Sylvain Jereme M 4

What Happened

• Sylvain Jereme, EVP and Chief Financial Officer of DexCom (DXCM), received 7,123 shares on Jan 29, 2026 upon vesting of performance-based restricted stock units (PSUs).
• On the same date, 2,652 shares were withheld by the company to cover tax withholding obligations at an effective price of $73.36 per share (withheld value ≈ $194,551). The withholding is a net settlement for taxes and is not a market sale by the insider.

Key Details

• Transaction date: January 29, 2026; Form filed Feb 2, 2026 (reporting period Jan 29, 2026). No late-filing flag provided in the supplied data.
• Award: 7,123 shares issued (code A); Withholding: 2,652 shares withheld for tax obligations (code F) at $73.36/share, totaling about $194,551.
• Footnotes: F1 — shares issued upon vesting of PSUs (granted Mar 8, 2023); F2 — withheld shares represent tax withholding and do not constitute a sale by the reporting person; F3 — filing notes 83,328 unvested RSUs remaining (breakdown by grant dates included).
• Shares owned after transaction: not specified in the provided excerpt; filing lists unvested RSU totals and ESPP shares per F3.

Context

• This was a PSU vesting event (award) with a net settlement for taxes — a routine compensation-related issuance rather than an open-market purchase or sale. Such withholding is common and typically reflects tax remittance, not a decision to liquidate holdings.